Precipio, Inc. Common Stock

Day range

$19.10 – $19.84

Open

$19.77

Prev close

$20.01

Volume

33.23K

Market cap

$35.82M

Shares out

1.79M

P/E

—

P/S

1.29

P/B

2.43

P/FCF

45.40

ROE

-8.2%

ROA

-5.7%

Debt/Equity

0.08

Div yield

0.00%

As of Oct 23, 2026

• Annual meeting resultsJun 15, 2026

  On June 15, 2026, Precipio, Inc. (the "Company") convened its Annual Meeting of stockholders for the purpose of holding a stockholder vote (the "Annual Meeting"). At the Annual Meeting, the stockholders of the Company voted: 1. To elect Richard Sandberg, Christina Valauri, and Jeffrey Cossman, M.D. as Class II directors for terms to expire in 2029 ("Proposal One"); 2. To ratify the appointment of CBIZ CPAs, P.C. ("CBIZ") as our independent registered public accounting firm for the year ending December 31, 2026 ("Proposal Two"). Proposals One and Proposal Two submitted to a vote of the Company's stockholders at the Annual Meeting were approved.

• Preliminary resultsFeb 27, 2026

  On February 25, 2026, Precipio, Inc. (the "Company") announced its preliminary (unaudited) financials for Q4-2025 and for its fiscal year 2025.

• Equity compensation grantDec 29, 2025

  The Committee approved the grant of an aggregate of 70,000 performance-based stock options to the named executive officers and additional performance-based stock options members of senior management under the Company's Amended and Restated 2017 Stock Option and Incentive Plan. The options will vest solely upon a performance condition being a 10-day volume-weighted average price (VWAP) of the Company's common stock exceeding $40 per share.

• Deal terminationSep 3, 2025

  Effective as of September 2, 2025, the Company terminated the Sales Agreement. Following the termination of the Sales Agreement, the Company may not offer or sell any additional shares of Common Stock under the Sales Agreement.

• Investor presentationAug 18, 2025

  On August 18, 2025, Precipio Inc posted an updated version of its investor presentation on the Company's investor relations website at https://www.precipiodx.com/wp-content/uploads/2025/08/prpodeck2025.pdf. A copy of the updated presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Days to cover

1.0

Short interest

68.64K

Avg volume

110.22K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
  positiveZacks Investment Research· Sep 22, 2026
• Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
  negativeGlobeNewswire Inc.· Jun 12, 2026
• Precipio to Present at the Planet MicroCap Las Vegas
  positiveGlobeNewswire Inc.· Jun 11, 2026
• Precipio Announces Q1 2026 Financial Results
  neutralGlobeNewswire Inc.· May 14, 2026
• Management team’s 2025 market-based Options have vested
  positiveGlobeNewswire Inc.· May 13, 2026